BioWorld

April 19, 2004

View Archived Issues

Immunicon Raises $48M In IPO; Lower Pricings Trend Continues

Following a recent trend of lower-than-expected pricings, Immunicon Corp. stepped up to the initial public offering plate on Friday, raising a total of $48 million. (BioWorld Today) Read More

Cytogen Brings In $26M To Increase Sales Force Size

Read More

Panel Discusses Potential Ways To Improve FDA Approval Cycle

Read More

Hybridon Signs Deal To Raise $11.8M For Cancer, HIV Drugs

Read More

Other News To Note

Read More